X
Get new exclusive access to healthcare business reports & breaking news
Abbott’s MitraClip for Heart Failure Patients
The Mitraclip, developed by Chicago-based Abbott Laboratories, can greatly reduce death rates in patients with severe heart failure, according to a new study published in the New England Journal of Medicine.
The tiny device inserted into the heart via a catheter greatly boosts survival rates among patients with severe heart failure. Cardiologists call the procedure “ a game changer.” The Food and Drug Administration (FDA) already approved the clip for patients too frail for surgery, but whose hearts are healthy except for a diseased mitral valve.
RELATED DIGITAL HEALTH NEWS
